Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering

Area of Science:

• Molecular biology
• Cell signaling
• Cancer research

Background:

• Galectin-1 (Gal-1) dimers are known to interact with cell surface receptors.
• Intracellular Gal-1 was previously hypothesized to directly interact with Ras proteins, potentially promoting tumor growth.
• Ras nanoclusters are critical for cellular signaling and are implicated in tumorigenesis.

Purpose of the Study:

• To revise the model of Galectin-1 interaction with H-Ras.
• To investigate the mechanism by which Gal-1 influences Ras nanocluster formation.
• To identify potential therapeutic targets in Ras-driven diseases.

Main Methods:

• Computational modeling to predict Gal-1/C-Raf-RBD complex structure.
• Mutational analysis to validate computational models.
• Cellular Förster Resonance Energy Transfer (FRET) and proximity ligation assays to confirm protein interactions.
• Experiments to assess the impact of Gal-1 on Ras nanoclustering.

Main Results:

• Galectin-1 (Gal-1) indirectly complexes with GTP-H-Ras through Ras effector proteins, specifically via the Ras-binding domain (RBD).
• Gal-1 interacts with Raf proteins in mammalian cells, confirmed by FRET and proximity ligation assays.
• Disruption of H-Ras-effector interactions significantly reduces H-Ras nanoclustering.
• Gal-1's dimer interface is crucial for regulating H-Ras and K-Ras nanoclustering differently.

Conclusions:

• The Galectin-1/Ras effector interface is a potential drug target for aberrant Ras signaling.
• Gal-1 influences Ras nanoclustering through indirect interactions with Ras effectors like Raf.
• Stacked dimers of Ras, Raf, and Gal-1 may form the basis of GTP-H-Ras nanoclusters at elevated Gal-1 levels.